[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342966-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342966-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrated-bulk-and-single-cell-rna-sequencing-identifies-an-aneuploidy-based-gene-signature-to-predict-sensitivity-of-lung-adenocarcinoma-to-traditional-chemotherapy-drugs-and-patientsprognosis","Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients’prognosis","","Lung adenocarcinoma (LUAD) patients frequently experience poor prognosis, and evidence linking aneuploidy-related genes to prognostic and immunotherapeutic performance remains limited. Using bulk RNA-seq data, Spearman-based screening identified aneuploidy-related genes, followed by univariate Cox and Lasso modeling to construct an aneuploidy-related riskscore (ARS). Bioinformatic findings were validated with cellular experiments and single-cell analyses including subtype clustering, SCENIC, and intercellular communication. Immune infiltration was assessed with ESTIMATE, ssGSEA, and CIBERSORT to relate ARS to the tumor immune microenvironment, supporting prediction of chemotherapy sensitivity and patient outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrated-bulk-and-single-cell-rna-sequencing-identifies-an-aneuploidy-based-gene-signature-to-predict-sensitivity-of-lung-adenocarcinoma-to-traditional-chemotherapy-drugs-and-patientsprognosis/342966/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrated-bulk-and-single-cell-rna-sequencing-identifies-an-aneuploidy-based-gene-signature-to-predict-sensitivity-of-lung-adenocarcinoma-to-traditional-chemotherapy-drugs-and-patientsprognosis/342966.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in lung adenocarcinoma?","Question",{"text":63,"@type":64},"It targets the poor prognosis of LUAD and the limited evidence on how aneuploidy-related genes can predict outcomes and immunotherapeutic capacity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the aneuploidy-related riskscore (ARS) model built?",{"text":68,"@type":64},"Aneuploidy-related genes were screened from bulk RNA sequencing data using a Spearman approach, then univariate Cox and Lasso regression were used to construct the ARS model.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the five-gene ARS signature indicate about prognosis and treatment response?",{"text":72,"@type":64},"A low ARS group showed longer overall survival, higher inflammatory infiltration, greater benefit from immunotherapy, and more active response to traditional chemotherapy drugs such as Erlotinib and Roscovitine.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342966,1790635799,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Submitted 4 February 2024 Accepted 19 May 2024  \nPublished 24 June 2024  \nCorresponding author  \nHaihua Guo, [guohh369@163.com](guohh369@163.com)[ ](guohh369@163.com)Academic editor  \nFanglin Guan  \nAdditional Information and Declarations can be found on page 20  \nDOI 10.7717/peerj.17545  \n Copyright 2024 Wang et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nIntegrated bulk and single-cell RNA sequencing identiﬁes an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients’prognosis  \nXiaobin Wang 1, *, Jiakuan Chen1, *, Chaofan Li2, Yufei Liu2, Shiqun Chen3, Feng Lv1, Ke Lan 1, Wei He2, Hongsheng Zhu4, Liang Xu4, Kaiyuan Ma4 and Haihua Guo 1  \n1 Department of Thoracic Surgery, Tangdu Hospital, Air Force Military Medical University, Xi’an, China  \n2 Department of Thoracic Surgery, The 986 Military Medical Hospital of the Air Force, Xi’an, China  \n3 Thoracic Surgery, Weinan Central Hospital, Weinan, China  \n4 Thoracic Surgery, Shaanxi Chenggu County Hospital, Chenggu, China  \n* These authors contributed equally to this work.  \nABSTRACT  \nBackground: Patients with lung adenocarcinoma (LUAD) often develop a poor prognosis. Currently, researches on prognostic and immunotherapeutic capacity of aneuploidy-related genes in LUAD are limited.  \nMethods: Genes related to aneuploidy were screened based on bulk RNA sequencing data from public databases using Spearman method. Next, univariate Cox and Lasso regression analyses were performed to establish an aneuploidy-related riskscore (ARS) model. Results derived from bioinformatics analysis were further validated using cellular experiments. In addition, typical LUAD cells were identiﬁed by subtype clustering, followed by SCENIC and intercellular communication analyses. Finally, ESTIMATE, ssGSEA and CIBERSORT algorithms were employed to analyze the potential relationship between ARS and tumor immune environment.  \nResults: A ﬁve-gene ARS signature was developed. These genes were abnormally high-expressed in LUAD cell lines, and in particular the high expression of CKS1B promoted the proliferative, migratory and invasive phenotypes of LUAD cell lines. Low ARS group had longer overall survival time, higher degrees of inﬂammatory inﬁltration, and could beneﬁt more from receiving immunotherapy. Patients in low ASR group responded more actively to traditional chemotherapy drugs (Erlotiniband Roscovitine) . The scRNA-seq analysis annotated 17 cell subpopulations into seven cell clusters. Core transcription factors (TFs) such as CREB3L1 and CEBPD were enriched in high ARS cell group, while TFs such as BCLAF1 and UQCRB were enriched in low ARS cell group. CellChat analysis revealed that high ARS cell groups communicated with immune cells via SPP1 (ITGA4-ITGB1) and MK (MDK-NCl) signaling pathways.  \nHow to cite this article Wang X, Chen J, Li C, Liu Y, Chen S, Lv F, Lan K, He W, Zhu H, Xu L, Ma K, Guo H. 2024. Integrated bulk and single-cell RNA sequencing identiﬁes an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients’ prognosis. PeerJ 12:e17545 DOI 10.7717/peerj.17545  \nConclusion: In this research, integrative analysis based on the ARS model provided a potential direction for improving the diagnosis and treatment of LUAD.  \nSubjects Bioinformatics, Molecular Biology, Immunology, Oncology  \nKeywords Aneuploidy, Bulk RNA sequencing, Single-cell RNA-sequencing, Prognostic signature, Immunotherapy, Lung adenocarcinoma  \nINTRODUCTION  \nLung adenocarcinoma (LUAD), as the main type of lung cancer (Sung et al., 2021; Schabath & Cote, 2019), has become a major cause of cancer-related mortality globally (Siegel et al., 2023) . The strong proliferation and invasion ability of LUAD cells is closely related to the poor survival rate of the cancer (Siegel, Miller & Jemal, 2019; Liu et al., 2021) . Currently, chemotherapy remains still one of the primary therapy","cbCainMZ78tWr97W","https://ap.wps.com/l/cbCainMZ78tWr97W","pdf",13450829,26,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## LUAD, prognosis, and chemotherapy resistance\n## Aneuploidy and aneuploidy-related gene markers\n## Bulk RNA-seq and single-cell RNA-seq approaches","[{\"question\":\"What problem does the study address in lung adenocarcinoma?\",\"answer\":\"It targets the poor prognosis of LUAD and the limited evidence on how aneuploidy-related genes can predict outcomes and immunotherapeutic capacity.\"},{\"question\":\"How was the aneuploidy-related riskscore (ARS) model built?\",\"answer\":\"Aneuploidy-related genes were screened from bulk RNA sequencing data using a Spearman approach, then univariate Cox and Lasso regression were used to construct the ARS model.\"},{\"question\":\"What does the five-gene ARS signature indicate about prognosis and treatment response?\",\"answer\":\"A low ARS group showed longer overall survival, higher inflammatory infiltration, greater benefit from immunotherapy, and more active response to traditional chemotherapy drugs such as Erlotinib and Roscovitine.\"}]","Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients’prognosis | PDF",1790049169,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/387a776747c2476ffc198de45170b2a3.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c44d45c2edb8f20bef00b255768017e.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0f6b04b32f0b15b3dc32122ce4abbdd.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e53005c992532697329f2bd2141984d2.webp",980,1268]